Three Amigos Stock Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sergio H who wrote (28085)	2/13/2002 8:59:10 PM
From: JoeinIowa	Read Replies (1) of 29382

Sergio, NPRO just does not do it for me. Looks basically like they are trying to get approval for the generic form of Taxol. Seems little doubt that it will happen but the competition will still be very high. If this was some new drug therapy I could generate a little excitement but if your big plan is to market a generic well .... Hard to say what their market share or sales could become. Obviously if you have a good feel for those numbers you could see when they might make money. I just see they are losing around $20M/year and have $15M in the bank. Jose

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next